News | ACC | March 03, 2023

Four New Studies Featuring Zio by iRhythm to be Presented at ACC.23/WCC

iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference 

iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference

March 3, 2023 —  iRhythm Technologies, Inc. , a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, will have the results of four studies presented by leading clinical investigators at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology (ACC.23/WCC) from March 4-6, 2023, in New Orleans, LA. 

These studies further strengthen iRhythm’s body of clinical and scientific evidence to differentiate its Zio suite of products and services. New research will include data from the CAMELOT study, the first and largest study of its kind1,2 to evaluate diagnostic yield, time to clinical diagnosis, retest rates, and healthcare resource utilization among different cardiac monitoring services, and will also detail initial clinical experience with the next generation of iRhythm’s ECG patch, the Zio monitor, which will be commercially available later this year. 

Clinical findings will be presented at the conference during the times listed below. 

Saturday, Mar. 4 

1:30 – 1:40 p.m. CDT, exact time may vary: “Initial Real World And Clinical Experience Of The Next Generation Ambulatory ECG Zio Monitor: Implications For Standard And Extended Wear Monitoring.” Presenter: Dr. Jay Alexander, cardiologist, NorthShore University HealthSystem and medical director, iRhythm.
 

1:45 – 2:30 p.m. CDT: “Prevalence And Prognostic Value Of Ventricular Tachycardia On Ambulatory ECG Monitoring.” Presenter: Dr. Krishna Pundi, fellow in cardiovascular medicine, Stanford University School of Medicine. 

Sunday, Mar. 5 

1:45 – 2:30 p.m. CDT: “CAMELOT: Comparative Effectiveness Of Ambulatory Monitors For Arrhythmia Diagnosis: A Retrospective Analysis Of Medicare Beneficiaries.” Presenter: Dr. Suneet Mittal, associate chair of cardiovascular services and director of electrophysiology, Valley Health System. 

Monday, Mar. 6 

12:45 – 1:30 p.m. CDT: “Comparison Of Patch Versus Multi-electrode Cardiac Monitoring For The Detection Of Arrhythmias: The COMPARE Study.” Presenter: Dr. Lohit Garg, assistant professor, University of Colorado Anschutz School of Medicine. 

To join iRhythm at ACC.23/WCC, please visit booth #129 to learn more. Clinicians and health care professionals can also RSVP for an educational event, “Cardiac Monitoring: Clinical Challenges, Evidence Gaps, and Patient Outcomes,” here

For more information: www.irhythmtech.com 

Find more ACC23 coverage here 


Related Content

News | Implantable Cardiac Monitor (ICM)

October 3, 2023 -- Boston Scientific launched the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation ...

Home October 03, 2023
Home
Feature | Implantable Cardiac Monitor (ICM)

The global cardiovascular diagnostic and monitoring devices market was valued at $14.2B in 2021 and is projected to ...

Home June 13, 2023
Home
News | Implantable Cardiac Monitor (ICM)

May 18, 2023 — Abbott announced its Assert-IQ insertable cardiac monitor (ICM) has received U.S. Food and Drug ...

Home May 18, 2023
Home
News | Implantable Cardiac Monitor (ICM)

May 4, 2023 — Avertix Medical, Inc., formerly known as Angel Medical Systems, Inc., a company focused on improving long ...

Home May 04, 2023
Home
News | Implantable Cardiac Monitor (ICM)
April 29, 2022 – Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small ...
Home April 29, 2022
Home
News | Implantable Cardiac Monitor (ICM)
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...
Home April 06, 2022
Home
News | Implantable Cardiac Monitor (ICM)

September 7, 2021 — Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of ...

Home September 07, 2021
Home
News | Implantable Cardiac Monitor (ICM)

August 9, 2021 - In association with Heart Rhythm 2021, Biotronik today announced that the latest implantable cardiac ...

Home August 09, 2021
Home
News | Implantable Cardiac Monitor (ICM)

June 13, 2021 — Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the ...

Home July 14, 2021
Home
News | Implantable Cardiac Monitor (ICM)

December 22, 2020 — The U.S. Food and Drug Administration (FDA) cleared Biotronik's Vital Data Sensor, which identifies ...

Home December 22, 2020
Home
Subscribe Now